Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

HPV 6/11, 16, 18 seroprevalence in men in two US cities.

Dunne EF, Nielson CM, Hagensee ME, Papenfuss MR, Harris RB, Herrel N, Gourlie J, Abrahamsen M, Markowitz LE, Giuliano AR.

Sex Transm Dis. 2009 Nov;36(11):671-4. doi: 10.1097/OLQ.0b013e3181bc094b.

PMID:
19809385
2.

Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.

Ji J, Sun HK, Smith JS, Wang H, Esser MT, Hu S, Pretorius RG, Chen W, Belinson JL, Qiao YL.

BMC Infect Dis. 2012 Jun 20;12:137. doi: 10.1186/1471-2334-12-137.

3.

Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.

Newall AT, Brotherton JM, Quinn HE, McIntyre PB, Backhouse J, Gilbert L, Esser MT, Erick J, Bryan J, Formica N, MacIntyre CR.

Clin Infect Dis. 2008 Jun 1;46(11):1647-55. doi: 10.1086/587895. Erratum in: Clin Infect Dis. 2008 Jul 15;47(2):302.

PMID:
18444790
4.

Prevalence of human papillomavirus antibodies in males and females in England.

Desai S, Chapman R, Jit M, Nichols T, Borrow R, Wilding M, Linford C, Lowndes CM, Nardone A, Pebody R, Soldan K.

Sex Transm Dis. 2011 Jul;38(7):622-9. doi: 10.1097/OLQ.0b013e31820bc880.

PMID:
21317688
5.
6.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812
7.

Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.

Kreimer AR, Alberg AJ, Viscidi R, Gillison ML.

Sex Transm Dis. 2004 Apr;31(4):247-56.

PMID:
15028941
8.

Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.

Nicol AF, Grinsztejn B, Friedman RK, Veloso VG, Cunha CB, Georg I, Pilotto JH, Moreira RI, Castro CA, Silver B, Viscidi RP.

J Clin Virol. 2013 Jun;57(2):147-51. doi: 10.1016/j.jcv.2013.02.007. Epub 2013 Mar 9.

PMID:
23490398
9.

Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.

Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER.

J Infect Dis. 2009 Oct 1;200(7):1059-67. doi: 10.1086/604729.

PMID:
19719390
10.

Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.

Thompson DL, Douglas JM Jr, Foster M, Hagensee ME, Diguiseppi C, Barón AE, Cameron JE, Spencer TC, Zenilman J, Malotte CK, Bolan G, Kamb ML, Peterman TA; Project RESPECT Study Group.

J Infect Dis. 2004 Nov 1;190(9):1563-74. Epub 2004 Sep 23.

PMID:
15478060
11.

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.

Olsson SE, Villa LL, Costa RL, Petta CA, Andrade RP, Malm C, Iversen OE, Høye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, von Krogh G, Lehtinen M, Paavonen J, Tamms GM, Giacoletti K, Lupinacci L, Esser MT, Vuocolo SC, Saah AJ, Barr E.

Vaccine. 2007 Jun 21;25(26):4931-9. Epub 2007 Apr 20.

PMID:
17499406
12.

Seroprevalence and risk factors for human papillomavirus in Taiwan.

Wang IJ, Viscidi R, Hwang KC, Lin TY, Chen CJ, Huang LM, Chen HH, Chen CJ.

J Trop Pediatr. 2008 Feb;54(1):14-8. Epub 2007 Nov 4.

PMID:
17984124
13.

Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994.

Hariri S, Dunne EF, Sternberg M, Unger ER, Meadows KS, Karem KL, Markowitz LE.

Sex Transm Dis. 2008 Mar;35(3):298-303.

PMID:
18091027
14.

Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.

Lu B, Hagensee ME, Lee JH, Wu Y, Stockwell HG, Nielson CM, Abrahamsen M, Papenfuss M, Harris RB, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):511-6. doi: 10.1158/1055-9965.EPI-09-0790. Epub 2010 Jan 19.

15.

Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.

Chen CJ, Viscidi RP, Chuang CH, Huang YC, Chiu CH, Lin TY.

J Clin Virol. 2007 Feb;38(2):126-30. Epub 2007 Jan 8.

PMID:
17210269
16.

Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006.

Introcaso CE, Dunne EF, Hariri S, Panicker G, Unger ER, Markowitz LE.

Sex Transm Infect. 2014 Sep;90(6):505-8. doi: 10.1136/sextrans-2013-051490. Epub 2014 Apr 19.

PMID:
24748563
17.

Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.

Iannacone MR, Michael KM, Giuliano AR, Waterboer T, Pawlita M, Rollison DE.

J Infect Dis. 2010 Mar;201(5):760-9. doi: 10.1086/650466.

PMID:
20105078
18.

Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study.

Lu B, Wu Y, Nielson CM, Flores R, Abrahamsen M, Papenfuss M, Harris RB, Giuliano AR.

J Infect Dis. 2009 Feb 1;199(3):362-71. doi: 10.1086/596050.

PMID:
19133808
19.

Prevalence and seroprevalence of high-risk human papillomavirus infection.

Kim MA, Oh JK, Chay DB, Park DC, Kim SM, Kang ES, Kim JH, Cho CH, Shin HR, Seo K.

Obstet Gynecol. 2010 Oct;116(4):932-40. doi: 10.1097/AOG.0b013e3181edbeba.

PMID:
20859158
20.

Seroprevalence of human papillomavirus type 16 in pregnant women.

Hagensee ME, Slavinsky J 3rd, Gaffga CM, Suros J, Kissinger P, Martin DH.

Obstet Gynecol. 1999 Nov;94(5 Pt 1):653-8.

PMID:
10546705

Supplemental Content

Support Center